CSF2 and melanoma: Another engineered virus encoding a cell-depleting anti-CTLA4 antibody and GM-CSF successfully eradicated tumors in multiple models, including breast (EMT6), colon (MC-38), and melanoma (B16) models, following intratumoral administration.